Development in the syllabus of Pharmaceutical Marketing & Management that is studied in the Bachelor of Pharmacy course of Bangladeshi Universities.        LOSECTIL stands beside acid survivors        Vitamin D Levels Linked to Parkinson's Symptoms        Keeping the newborn warm at home at winter        Itís time to prevent cervical cancer        Huge Rise in CT, MRI, Ultrasound Scan Use: Study        Exercise May Delay Early Aging of People With Diabetes        Alzheimer's Drug Shows Some Promise in Trials        Obesity, Depression Blamed for Daytime Sleepiness Epidemic        Fruits, Veggies May Help Smokers Quit     

Member Sign In
Forgot Your
Username & Password?


Not a Member?
Please Sign Up Here


 
 
Sr. Executive / Executive, Production; THE IBN SINA PHARMACEUTICAL IND LTD

 
 
 Pioglitazone (Diabetes Drug) may increase the risk of bladder cancer: FDA Warned
 
Update: 2011-06-17
The U.S. Food and Drug Administration has warned consumers and health care professionals that pioglitazone (see all the brand names in Bangladesh) may increase the risk of bladder cancer when used for more than one year.

Pioglitazone is a thiazolidinedione, a drug class which also includes the diabetes drug rosiglitazone (see all the brand names in Bangladesh). Rosiglitazone was pulled off the International market in May because it was linked to an increased risk of myocardial infarction. Pioglitazone is used to control blood sugar levels and is sold alone or in combination with metformin and glimepiride (see all the brand names in Bangladesh).

The new bladder cancer warning will appear on the label of pioglitazone and is based on the FDA's review of data from an ongoing study that involves more than 193,000 patients with diabetes. The data revealed a 40 percent increased risk of bladder cancer in patients taking the drug longer than 12 months as compared to those never exposed to pioglitazone. Both France and Germany recently pulled pioglitazone from the market based on similar findings.

The FDA recommends that patients should talk to their health care provider regarding any concerns about the drug and should contact their physician if they are experiencing any symptoms of bladder cancer.

According to the FDA, "the benefits of blood sugar control with pioglitazone should be weighed against the unknown risks for cancer recurrence."


please click here to know more information.



source: US-FDA
 
Other News
Itís time to prevent cervical cancer
World Health Day - April 07, 2011
Blood Stored Too Long May Threaten Patient Safety
Diet for cancer patients: choosing the best option
Exercise May Delay Early Aging of People With Diabetes
World no tobacco day -- May 31,2011
World Asthma Day - May 03, 2011
December 01, 2010 - World AIDS day
See all the news